Novartis AG - 예탁증서(보통주)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionLindbrook Capital, Llc
Latest Disclosed Ownership3,864 shares
Latest Disclosed Value $ 430,759
Lindbrook Capital, Llc reports 1.26% increase in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 5, 2025 - Lindbrook Capital, Llc filed a 13F-HR form disclosing ownership of 3,864 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $430,759 USD as of March 31, 2025. The entity filed a previous 13F-HR on February 6, 2025 disclosing 3,816 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 1.26% during the quarter. The current value of the position is $576,354 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-05-05 2025-03-31 13F NOVARTIS AG ADR ADR 66987V109 3,864 48 1.26 431 15.90 0.0397
2025-02-06 2024-12-31 13F NOVARTIS AG ADR ADR 66987V109 3,816 -113 -2.88 371 -17.74 0.0335
2024-11-01 2024-09-30 13F NOVARTIS AG ADR ADR 66987V109 3,929 11 0.28 452 8.15 0.0400
2024-07-31 2024-06-30 13F NOVARTIS AG ADR ADR 66987V109 3,918 142 3.76 417 14.25 0.0392
2024-04-25 2024-03-31 13F NOVARTIS AG ADR ADR 66987V109 3,776 52 1.40 365 -2.93 0.0342
2024-02-01 2023-12-31 13F NOVARTIS AG ADR ADR 66987V109 3,724 -425 -10.24 376 -10.90 0.0375
2023-10-25 2023-09-30 13F NOVARTIS AG ADR ADR 66987V109 4,149 -550 -11.70 423 -10.97 0.0473
2023-07-31 2023-06-30 13F NOVARTIS AG ADR ADR 66987V109 4,699 -63 -1.32 474 8.22 0.0505
2023-04-26 2023-03-31 13F NOVARTIS AG ADR ADR 66987V109 4,762 -825 -14.77 438 -13.44 0.0513
2023-01-25 2022-12-31 13F NOVARTIS AG ADR ADR 66987V109 5,587 -166 -2.89 507 15.79 0.0624
2022-11-10 2022-09-30 13F NOVARTIS AG ADR ADR 66987V109 5,753 56 0.98 437 -9.34 0.0737
2022-08-01 2022-06-30 13F NOVARTIS AG ADR ADR 66987V109 5,697 -148 -2.53 482 -6.04 0.0797
2022-04-21 2022-03-31 13F NOVARTIS AG ADR ADR 66987V109 5,845 -402 -6.44 513 -6.04 0.0792
2022-01-18 2021-12-31 13F NOVARTIS AG ADR ADR 66987V109 6,247 1,684 36.91 546 46.38 0.0831
2021-11-05 2021-09-30 13F NOVARTIS AG ADR ADR 66987V109 4,563 -51 -1.11 373 -11.40 0.0978
2021-07-27 2021-06-30 13F NOVARTIS AG ADR ADR 66987V109 4,614 9 0.20 421 6.85 0.0941
2021-04-28 2021-03-31 13F NOVARTIS AG ADR ADR 66987V109 4,605 1,467 46.75 394 33.11 0.0887
2021-01-27 2020-12-31 13F NOVARTIS AG ADR ADR 66987V109 3,138 -65 -2.03 296 6.09 0.0723
2020-11-03 2020-09-30 13F NOVARTIS AG ADR ADR 66987V109 3,203 793 32.90 279 32.86 0.0768
2020-07-27 2020-06-30 13F NOVARTIS AG ADR ADR 66987V109 2,410 -108 -4.29 210 0.96 0.0623
2020-04-22 2020-03-31 13F NOVARTIS AG ADR ADR 66987V109 2,518 -2,034 -44.68 208 -51.74 0.0786
2020-01-27 2019-12-31 13F NOVARTIS AG ADR ADR 66987V109 4,552 -19 -0.42 431 8.56 0.1500
2019-10-30 2019-09-30 13F NOVARTIS AG ADR ADR 66987V109 4,571 188 4.29 397 -0.75 0.1499
2019-07-24 2019-06-30 13F NOVARTIS AG ADR ADR 66987V109 4,383 -813 -15.65 400 -19.84 0.1543
2019-04-23 2019-03-31 13F NOVARTIS AG ADR ADR 66987V109 5,196 144 2.85 499 15.24 0.1987
2019-02-07 2018-12-31 13F NOVARTIS AG ADR ADR 66987V109 5,052 5,052 433 0.2132
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.